Vaxart Announces Adjournment of Annual Meeting of Stockholders
'In recent days, we have engaged in constructive conversations with some of our larger stockholders to address their questions and concerns regarding the reverse stock split proposal,' said Steven Lo, Chief Executive Officer of Vaxart. 'I am pleased to report that following these discussions, many have indicated their intention to vote in favor of Proposal No. 2. This shift underscores the increasing understanding of the necessity of this proposal to ensure our continued Nasdaq listing as we focus on our exciting upcoming milestones.'
The reconvened Annual Meeting will be held in a virtual-only format, which can be accessed by visiting http://www.virtualshareholdermeeting.com/VXRT2025 and entering the 16‐digit control number included in your Notice of Internet Availability of Proxy Materials, on your proxy card or in the instructions that accompanied your proxy materials.
During the adjournment, Vaxart continues to solicit votes from its stockholders with respect to all proposals set forth in the Proxy Statement.
Proxies previously submitted with respect to the Annual Meeting will be voted on all applicable proposals at the adjourned Annual Meeting unless properly revoked in accordance with the procedures described in the Proxy Statement, and stockholders who have previously submitted a proxy or otherwise voted need not take any action.
Both leading independent proxy advisory firms, Institutional Shareholder Services ('ISS') and Glass Lewis, recommend that stockholders support Proposal No. 2. A message from Dr. Sean Tucker, Founder and Chief Scientific Officer, and a fact sheet that addresses several misconceptions about the proposed reverse stock split can be found on Vaxart's investor relations website at investors.vaxart.com.
Vaxart encourages all stockholders of record on March 26, 2025 who have not yet voted to do so by 11:59 p.m. Eastern Time on June 12, 2025. The Company also reminds those who have previously voted against Proposal No. 2 that they can change their vote in favor of the proposal.
If you have any questions or need assistance with voting, please contact Vaxart's proxy solicitation firm:
Campaign Management, LLCToll-Free: 1-855-264-1527Email: info@campaign-mgmt.com
About Vaxart Vaxart is a clinical-stage biotechnology company developing a range of oral recombinant vaccines based on its proprietary delivery platform. Vaxart vaccines are designed to be administered using pills that can be stored and shipped without refrigeration and eliminate the risk of needle-stick injury. Vaxart believes that its proprietary pill vaccine delivery platform is suitable to deliver recombinant vaccines, positioning the company to develop oral versions of currently marketed vaccines and to design recombinant vaccines for new indications. Vaxart's development programs currently include pill vaccines designed to protect against coronavirus, norovirus and influenza, as well as a therapeutic vaccine for human papillomavirus (HPV), Vaxart's first immune-oncology indication. Vaxart has filed broad domestic and international patent applications covering its proprietary technology and creations for oral vaccination using adenovirus and TLR3 agonists.
Note Regarding Forward-Looking Statements This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended (the 'Securities Act') and Section 21E of the Securities Exchange Act of 1934, as amended (the 'Exchange Act'), which are subject to the 'safe harbor' created by those sections, concerning our business, operations, and financial performance and condition as well as the annual meeting of stockholders, our plans, objectives, and expectations for business operations, funding, and financial performance and condition. Any statements contained herein that are not of historical facts may be deemed to be forward-looking statements. You can identify these statements by words such as 'anticipate,' 'assume,' 'believe,' 'could,' 'estimate,' 'expect,' 'intend,' 'may,' 'plan,' 'should,' 'will,' 'would,' and other similar expressions that are predictions of or indicate future events and future trends. These forward-looking statements are based on current expectations, estimates, forecasts, and projections about our business and the industry in which we operate and management's beliefs and assumptions and are not guarantees of future performance or development and involve known and unknown risks, uncertainties, and other factors that are in some cases beyond our control. As a result, any or all of our forward-looking statements in this press release may turn out to be inaccurate. Factors that could materially affect our business operations and financial performance and condition include, but are not limited to, those risks and uncertainties described under 'Item 1A - Risk Factors' in our Annual Report on Form 10-K for the year ended December 31, 2024 and any risk factors disclosed in any subsequent Quarterly Reports on Form 10-Q. You are urged to consider these factors carefully in evaluating the forward-looking statements and are cautioned not to place undue reliance on the forward-looking statements. The forward-looking statements are based on information available to us as of the date of this press release. Unless required by law, we do not intend to publicly update or revise any forward-looking statements to reflect new information or future events or otherwise. You should, however, review the factors and risks we describe in the reports we will file from time to time with the SEC after the date of this press release.
Participants in the SolicitationThe Company and its directors, executive officers, and certain employees and other persons may be deemed to be participants in the solicitation of proxies from the Company's stockholders in connection with the business to be conducted at the annual meeting of stockholders. Investors and security holders may obtain more detailed information regarding the names, affiliations, and interests of the Company's directors and executive officers in the definitive proxy statement filed in connection with the annual meeting of stockholders as well as the Company's other filings with the U.S. Securities and Exchange Commission (the 'SEC'), all of which may be obtained free of charge at the website maintained by the SEC at www.sec.gov.
Contact
Vaxart Media and Investor RelationsMatt SteinbergFINN PartnersIR@vaxart.com(646) 871-8481
This press release was published by a CLEAR® Verified individual.Sign in to access your portfolio
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Insider
an hour ago
- Business Insider
Trump Fires Labor Stats Chief after July Jobs Miss and Revisions Hit Market
President Donald Trump removed Bureau of Labor Statistics Commissioner (BLS) Erika McEntarfer on Friday, after the agency reported July job growth came in far below forecasts. The BLS posted an increase of 73,000 nonfarm payrolls for the month, missing expectations and triggering a sharp market reaction. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. The president announced the decision on Truth Social. He claimed the commissioner, appointed in 2024 under President Joe Biden, had produced flawed data. Trump alleged the report was manipulated to harm the economy's perceived strength. However, no official evidence supports this claim. Until a replacement is confirmed, Deputy Commissioner William Wiatrowski will serve as acting head of the agency. Powell in Trump's Crosshairs In the same post, Trump criticized Federal Reserve Chair Jerome Powell. He called for Powell's removal, citing interest rate decisions that, in his view, counteracted the broader economic policy. On Wednesday, the Federal Open Market Committee voted to hold the benchmark rate steady. Markets have now priced in a strong chance of a rate cut in September. The BLS also revised May and June job totals lower by a combined 258,000. That brought the three-month average to 35,000, the weakest stretch since April 2020. Economists note revisions are standard and reflect updated data, not political bias. Markets moved lower after the release. The Dow Jones Industrial Average (DJIA) fell over 500 points. The Nasdaq dropped more than 2%. Treasury yields declined as traders adjusted rate expectations. Data Integrity in Focus Critics of the decision include William Beach, a 2017 Trump appointee and former BLS chief. He said the move threatens the agency's independence and the reliability of federal data. Multiple public sector groups have raised similar concerns. The Bureau of Labor Statistics is part of the Department of Labor and provides key reports on jobs, inflation, and productivity. Its data is used by investors, businesses, and policymakers. The White House has promoted prior reports as signs of labor strength. Following the June numbers, it called the figures a 'June Boom.' Trump has frequently highlighted payroll gains while in office. The latest report, along with the firing, raises new focus on how economic data is produced and viewed during the 2025 election cycle.
Business Insider
an hour ago
- Business Insider
‘Great Expectations,' Says Top Investor About Palantir Stock
The weight of expectations can be a heavy burden to bear. It's not clear if Palantir Technologies (NASDAQ:PLTR) has gotten this memo. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Indeed, the company has been on quite a roll, and doesn't seem to be showing any signs of slowing down. Another major boost came just last week, as Palantir and the U.S. army agreed on a deal that could be worth up to $10 billion over the coming decade. Reflecting this strong performance, PLTR's share price is up over 540% for the past twelve months. Expectations are high once more as the company gears up to release its Q2 2025 numbers on Monday, August 4 after the market closes. The market is expecting Palantir to report $939.47 million in sales (Palantir itself has guided for $934 to $938 million), numbers which would represent year-over-year growth approaching 40%. Will the company outpace projections yet again? One top investor known as Deep Value Investing believes the rip-roaring Palantir will succeed in doing so. However, the 5-star investor offers a word of caution going forward. 'Even though revenue could have a big upside from this contract, there is a risk of disappointment from a margin perspective,' explains Deep Value, who is among the top 4% of TipRanks' stock pros. The investor further explains that despite Palantir's incredible run, it's not all sunshine and rainbows. For instance, the company is struggling to propel commercial adoption outside of the U.S. – '[Palantir CEO Alex] Karp doesn't have much hope in Europe (from a commercial perspective).' When it comes to the rate of commercial growth in the U.S., this has indeed been astounding (71% year-over-year during Q1 2025). However, the so-called 'total contract value' from this segment is $810 million, which the investor acknowledges pales in comparison to the very high price-to-earnings ratio of 687x that the company is trading at. Though the U.S. army deal is clearly a big win – and provides the 'ultimate confirmation' of Palantir's technology – Deep Value worries that the agreement could decrease the company's margins. 'While these contracts will support the revenue growth, currently in the mid-40s for the government segment, they will most likely pressure profitability,' Deep Value adds. All that being said, the investor remains bullish on Palantir on the eve of the company's Q2 earnings report. Deep Value will be eager to understand how quickly the $10 billion deal will translate into revenues, while also keeping a watchful eye on operating income guidance for the remainder of the year. Summing it all up, Deep Value Investing is assigning a Buy rating for Palantir. (To watch Deep Value Investing's track record, click here) Wall Street is not quite as bullish. With 10 Hold ratings far outpacing 4 Buys and 3 Sells, which give PLTR a consensus Hold (i.e. Neutral) rating. PLTR's 12-month average price target of $111.14 has a downside of ~28%. (See PLTR stock forecast) To find good ideas for AI stocks trading at attractive valuations, visit TipRanks' Best Stocks to Buy, a tool that unites all of TipRanks' equity insights.
Yahoo
2 hours ago
- Yahoo
MercadoLibre (MELI) Q2 Earnings Report Preview: What To Look For
Latin American e-commerce and fintech company MercadoLibre (NASDAQ:MELI) will be reporting results this Monday afternoon. Here's what to expect. MercadoLibre beat analysts' revenue expectations by 8.1% last quarter, reporting revenues of $5.94 billion, up 37% year on year. It was a strong quarter for the company, with an impressive beat of analysts' EBITDA estimates and impressive growth in its users. It reported 66.6 million daily active users, up 24.5% year on year. Is MercadoLibre a buy or sell going into earnings? Read our full analysis here, it's free. This quarter, analysts are expecting MercadoLibre's revenue to grow 28.9% year on year to $6.54 billion, slowing from the 41.5% increase it recorded in the same quarter last year. Adjusted earnings are expected to come in at $11.75 per share. Heading into earnings, analysts covering the company have grown increasingly bearish with revenue estimates seeing 3 downward revisions over the last 30 days (we track 7 analysts). MercadoLibre has a history of exceeding Wall Street's expectations, beating revenue estimates every single time over the past two years by 7.9% on average. Looking at MercadoLibre's peers in the online marketplace segment, some have already reported their Q2 results, giving us a hint as to what we can expect. Shutterstock delivered year-on-year revenue growth of 21.3%, beating analysts' expectations by 7.5%, and eBay reported revenues up 6.1%, topping estimates by 3.1%. Shutterstock's stock price was unchanged after the resultswhile eBay was up 18.5%. Read our full analysis of Shutterstock's results here and eBay's results here. Investors in the online marketplace segment have had steady hands going into earnings, with share prices flat over the last month. MercadoLibre is down 4.6% during the same time and is heading into earnings with an average analyst price target of $2,856 (compared to the current share price of $2,385). Today's young investors likely haven't read the timeless lessons in Gorilla Game: Picking Winners In High Technology because it was written more than 20 years ago when Microsoft and Apple were first establishing their supremacy. But if we apply the same principles, then enterprise software stocks leveraging their own generative AI capabilities may well be the Gorillas of the future. So, in that spirit, we are excited to present our Special Free Report on a profitable, fast-growing enterprise software stock that is already riding the automation wave and looking to catch the generative AI next. StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here.
